{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihuwubzbgjvmtoo2t4sd3ydjkunc3qaz4ip3xny72fuxjml5m2jbm",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mnfjozzyfxx2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiann2wke56gqzferqep3tqvmjl4wi7aqxxch753mbmvgtipcpi42e"
    },
    "mimeType": "image/jpeg",
    "size": 89659
  },
  "path": "/news/2026-06-antibiotic-drug-resistant-bacteria-previously.html",
  "publishedAt": "2026-06-03T12:00:05.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Researchers at McMaster University have discovered a new antibiotic that kills some of the world's most dangerous and drug-resistant bacteria—and does so by targeting a previously unknown vulnerability, opening the door to an entirely new class of treatments. The new compound, called manikomycin, was identified by a team led by McMaster Professor Gerry Wright and has shown early effectiveness against priority pathogens including Salmonella, E. coli, and Klebsiella.",
  "title": "New antibiotic kills drug-resistant bacteria by targeting previously unknown vulnerability"
}